Page last updated: 2024-11-10

chlormadinol acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chlormadinol acetate: structure given in first source; RN given refers to (3beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080592
SCHEMBL ID1406037
MeSH IDM0164832

Synonyms (16)

Synonym
17-acetoxy-6-chloro-3-hydroxypregna-4,6-dien-20-one
pregna-4,6-dien-20-one, 17-(acetyloxy)-6-chloro-3-hydroxy-, (3beta)-
chlormadinol acetate
6-chlor-6-dehydro-17-hydroxyprogesteron acetat
cmla
3114-44-1
ici 39575
nsc 92338
stg 155
[(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-6-chloro-3-hydroxy-10,13-dimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
SCHEMBL1406037
J-018259
DTXSID30953232
6-chloro-3-hydroxy-20-oxopregna-4,6-dien-17-yl acetate
3'-hydroxychlormadinone acetate
(3')-17-(acetyloxy)-6-chloro-3-hydroxypregna-4,6-dien-20-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other2 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]